Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy

被引:43
作者
Nomura, T
Ohkusa, T
Okayasu, I
Yoshida, T
Sakamoto, M
Hayashi, H
Benno, Y
Hirai, S
Hojo, M
Kobayashi, O
Terai, T
Miwa, H
Takei, Y
Ogihara, T
Sato, N
机构
[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa, Japan
[3] RIKEN, Inst Phys & Chem Res, Japan Collect Microorganisms, Wako, Saitama 35101, Japan
[4] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 1138421, Japan
关键词
D O I
10.1111/j.1365-2036.2005.02428.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We proposed that Fusobacterium varium is one of the causative agents in ulcerative colitis. Aim: To examine the efficacy of antibiotic combination therapy against F. varium and to investigate the mucosa-associated bacteria before and after the therapy using a new molecular approach. Methods: Twenty patients with ulcerative colitis were randomly assigned into the antibiotic treatment group (amoxicillin, tetracycline and metronidazole for 2 weeks) and no-antibiotics group. Clinical assessment, colonoscopic and histological evaluations were performed at 0 and 3-5 months after the treatment. DNA from mucosal bacteria was isolated from biopsy specimens. We investigated the mucosa-associated bacterial components by terminal restriction fragment length polymorphism with the restriction enzyme HhaI and MspI, and quantified the change in the number of bacteria by real-time polymerase chain reaction. Immunohistochemical detection of F. varium in biopsy specimens was also performed. Results: After the treatment, the clinical assessment, colonoscopic and histological scores improved in the antibiotic group compared with the control group. Three peaks of terminal restriction fragment length polymorphism decreased after treatment only in the antibiotic group. Eubacterium rectale, Dorea formicigenerans, Clostridium clostridioforme and F. varium were included in these peaks. Based on the real-time polymerase chain reaction study, only F. varium was significantly reduced after treatment. In the immunostaining, post-treatment scores in treatment group were significantly lower than that in control group. Conclusions: Antibiotics combination therapy was effective for ulcerative colitis. The number of mucosa-associated F. varium significantly decreased after the treatment.
引用
收藏
页码:1017 / 1027
页数:11
相关论文
共 32 条
[1]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[2]  
BENNO Y, 1990, ECOLOGY ROLE INTESTI, P57
[3]  
BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123
[4]   Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease [J].
Cario, E ;
Podolsky, DK .
INFECTION AND IMMUNITY, 2000, 68 (12) :7010-7017
[5]   CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J].
CHAPMAN, RW ;
SELBY, WS ;
JEWELL, DP .
GUT, 1986, 27 (10) :1210-1212
[6]   Isolating PCR-quality DNA from human feces with a soil DNA kit [J].
Clement, BG ;
Kitts, CL .
BIOTECHNIQUES, 2000, 28 (04) :640-+
[7]   DOUBLE-BLIND CONTROLLED TRIAL OF ORAL VANCOMYCIN AS ADJUNCTIVE TREATMENT IN ACUTE EXACERBATIONS OF IDIOPATHIC COLITIS [J].
DICKINSON, RJ ;
OCONNOR, HJ ;
PINDER, I ;
HAMILTON, I ;
JOHNSTON, D ;
AXON, ATR .
GUT, 1985, 26 (12) :1380-1384
[8]  
EZAKI T, 2001, ANN REP YAKULT BIOSC, V9, P31
[9]   Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases [J].
Fujita, H ;
Eishi, Y ;
Ishige, I .
JOURNAL OF GASTROENTEROLOGY, 2002, 37 (07) :509-516
[10]   Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation [J].
Hayashi, H ;
Sakamoto, M ;
Benno, Y .
MICROBIOLOGY AND IMMUNOLOGY, 2002, 46 (12) :819-831